MTNB
Matinas Biopharma Hl
Description:
Matinas BioPharma Holdings Inc. (MTNB) is a clinical-stage biopharmaceutical company based in Bedminster, New Jersey, focused on advancing innovative oral lipid-based delivery systems for therapeutics that target both infectious diseases and chronic conditions. Leveraging its proprietary formulations, the company is dedicated to improving treatment efficacy and patient adherence, addressing critical unmet medical needs in the healthcare landscape. With a robust pipeline of candidate products and strategic partnerships, Matinas BioPharma represents a promising investment opportunity in the biotechnology arena, making it an attractive consideration for institutional investors seeking cutting-edge solutions to enhance patient outcomes.
Address:
1545 ROUTE 206 SOUTH, BEDMINSTER, NJ, UNITED STATES, 07921
Fiscal year end:
December
Market capitalization:
$7.56 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
11 years:
-97%
How much will you get:
$35
Prices dates:
18-08-2014: $40.00 and 31-10-2025: $1.38